Proof-of-concept trial may provide additional treatment option beyond lipid lowering for CV risk reduction

Media formats available:

The role of inflammation in atherosclerosis
The role of inflammation in atherosclerosis
Inflammation
The role of inflammation in atherosclerosis
- Peter Libby, MD
Ongoing benefit with bempedoic acid in reducing total incidence of MACE
Ongoing benefit with bempedoic acid in reducing total incidence of MACE
ESC Congress 2023
Ongoing benefit with bempedoic acid in reducing total incidence of MACE
- Stephen Nicholls, MD
Colchicine fails to reduce perioperative AF or MI in patients undergoing major thoracic surgery
Colchicine fails to reduce perioperative AF or MI in patients undergoing major thoracic surgery
ESC Congress 2023
Colchicine fails to reduce perioperative AF or MI in patients undergoing major thoracic surgery
- David Conen, MD
Residual inflammatory risk is major driver of CV events and mortality in statin-treated patients
Residual inflammatory risk is major driver of CV events and mortality in statin-treated patients
ACC.23
Residual inflammatory risk is major driver of CV events and mortality in statin-treated patients
- Prof. Peter Libby, MD

PACE-CME